Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
drugs
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
akcea therapeutics
anylam pharmaceuticals
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer
cardiomyopathy
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
entrectinib
express scripts
fda
foundation medicine
indiana blog main
indiana top stories
inotersen
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
merck
national
neuropathy
new england journal of medicine
new york
ntrk
What
approved
drug
2
×
fda
genetic
2
×
oks
ago
akcea
alnylam
amyloidosis
attr
available
battle
cancer
debilitating
deeper
disease
dna
fingerprint
going
matter
medicine
medicines
nd
new
patients
pfizer
rare
second
sets
targets
time
tissues
transthyretin
tumor's
world
year
Language
Current search:
genetic
×
drug
×
drugs
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues